$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp

2016 Q2 Form 10-Q Financial Statement

#000114420416104276 Filed on May 23, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2016 Q1 2015 Q4
Revenue $0.00 $102.00 $0.00
YoY Change -9.73%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% 0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $14.11K $4.811K $10.00K
YoY Change -24.42% -50.68% 0.0%
Operating Profit -$14.11K -$4.709K
YoY Change -24.42% 157.46%
Interest Expense $4.250K
YoY Change -63.31%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$14.11K -$8.959K -$10.00K
YoY Change -24.25% -22.65% 0.0%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$24.70K -$8.959K -$20.00K
YoY Change 11.53% -22.65% 100.0%
Net Earnings / Revenue -8783.33%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$1.972K -$3.945K
COMMON SHARES
Basic Shares Outstanding 5.073M shares 5.073M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2 2016 Q1 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables
Total Short-Term Assets $0.00 $1.816K $1.838K
YoY Change -100.0% 831.28% 796.59%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.277K $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $1.816K $1.838K
Total Long-Term Assets $4.277K $0.00 $0.00
Total Assets $4.277K $1.816K $1.838K
YoY Change 1052.83% 831.28% 796.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.14K $15.64K $10.86K
YoY Change 141.52% 399.94% 8.94%
Accrued Expenses $0.00 $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $20.00K $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $103.8K $86.56K $83.33K
YoY Change 80.58% 146.15% 134.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $103.8K $86.56K $83.33K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $103.8K $86.56K $83.33K
YoY Change 80.58% 146.15% 134.11%
SHAREHOLDERS EQUITY
Retained Earnings -$213.7K -$189.0K -$180.0K
YoY Change 41.61% 53.64%
Common Stock $5.073K $5.073K $5.073K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$99.53K -$84.75K -$81.49K
YoY Change
Total Liabilities & Shareholders Equity $4.277K $1.816K $1.838K
YoY Change 1052.83% 831.28% 796.59%

Cashflow Statement

Concept 2016 Q2 2016 Q1 2015 Q4
OPERATING ACTIVITIES
Net Income -$24.70K -$8.959K -$20.00K
YoY Change 11.53% -22.65% 100.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$10.00K $0.00 $10.00K
YoY Change -100.0% -200.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 0.000 -10.00K
YoY Change -100.0% -200.0%
NET CHANGE
Cash From Operating Activities -10.00K 0.000 10.00K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 10.00K 0.000 -10.00K
Net Change In Cash 0.000 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$10.00K $0.00 $10.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 dei Amendment Flag
AmendmentFlag
false
CY2016Q1 dei Document Type
DocumentType
10-Q
CY2016Q1 us-gaap Liabilities
Liabilities
86564 USD
CY2015Q4 us-gaap Liabilities
Liabilities
83330 USD
CY2016Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2016Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99186 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
93483 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189007 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-180048 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
-84748 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-81492 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1816 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1838 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4811 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9687 USD
CY2016Q1 us-gaap Operating Expenses
OperatingExpenses
4811 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
9754 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4709 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1829 USD
CY2016Q1 dei Entity Registrant Name
EntityRegistrantName
Original Source Entertainment, Inc.
CY2016Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001500198
CY2016Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
52652 USD
CY2016Q1 dei Trading Symbol
TradingSymbol
OSOK
CY2016Q1 us-gaap Cash
Cash
1816 USD
CY2015Q4 us-gaap Cash
Cash
1838 USD
CY2016Q1 us-gaap Assets Current
AssetsCurrent
1816 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
1838 USD
CY2016Q1 us-gaap Assets
Assets
1816 USD
CY2015Q4 us-gaap Assets
Assets
1838 USD
CY2016Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15643 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16659 USD
CY2016Q1 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
52652 USD
CY2016Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
17634 USD
CY2015Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
13619 USD
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
86564 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
83330 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2016Q1 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
635 USD
CY2015Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
400 USD
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
102 USD
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
113 USD
CY2016Q1 us-gaap Interest Expense
InterestExpense
4250 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
11583 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8959 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11583 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-8959 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-11583 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2016Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2016Q1 us-gaap Accretion Of Discount
AccretionOfDiscount
4015 USD
CY2015Q1 us-gaap Accretion Of Discount
AccretionOfDiscount
1829 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1016 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9837 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5725 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-19591 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5703 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
19581 USD
CY2016Q1 osok Noncash Investing And Financing Items Gain On Forgiveness Of Related Party Notes Payable
NoncashInvestingAndFinancingItemsGainOnForgivenessOfRelatedPartyNotesPayable
0 USD
CY2015Q1 osok Noncash Investing And Financing Items Gain On Forgiveness Of Related Party Notes Payable
NoncashInvestingAndFinancingItemsGainOnForgivenessOfRelatedPartyNotesPayable
31144 USD
CY2016Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
0 USD
CY2016Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2016Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-22 USD
CY2015Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-10 USD
CY2014Q4 us-gaap Cash
Cash
205 USD
CY2015Q1 us-gaap Cash
Cash
195 USD
CY2016Q1 dei Document Period End Date
DocumentPeriodEndDate
2016-03-31
CY2016Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2016Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2016Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2016Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5073000 shares
CY2014Q1 us-gaap Minority Interest Ownership Percentage By Parent
MinorityInterestOwnershipPercentageByParent
1 pure
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2016Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2015Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7581 USD
CY2016Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
5703 USD
CY2015Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
12000 USD
CY2016Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
52652 USD
CY2015Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
52652 USD
CY2016Q1 osok Increase Decrease In Accrued Liabilities Related Parties
IncreaseDecreaseInAccruedLiabilitiesRelatedParties
235 USD

Files In Submission

Name View Source Status
0001144204-16-104276-index-headers.html Edgar Link pending
0001144204-16-104276-index.html Edgar Link pending
0001144204-16-104276.txt Edgar Link pending
0001144204-16-104276-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
osok-20160331.xml Edgar Link completed
osok-20160331.xsd Edgar Link pending
osok-20160331_cal.xml Edgar Link unprocessable
osok-20160331_def.xml Edgar Link unprocessable
osok-20160331_lab.xml Edgar Link unprocessable
osok-20160331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v440417_10-q.htm Edgar Link pending
v440417_ex31.htm Edgar Link pending
v440417_ex32.htm Edgar Link pending